Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bioblast Pharma Ltd (NASDAQ:ORPN)

1.05
Delayed Data
As of 3:26pm ET
 -0.0813 / -7.19%
Today’s Change
0.92
Today|||52-Week Range
7.95
+0.86%
Year-to-Date
No recent news for Bioblast Pharma Ltd.

Today’s Trading

Previous close1.13
Today’s open1.14
Day’s range1.02 - 1.14
Volume201,426
Average volume (3 months)82,252
Market cap$18.5M
Dividend yield--
Data as of 3:26pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)-89.47%
Earnings growth (this year)+2.78%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.90

Competitors

 Today’s
change
Today’s
% change
APTOAptose Biosciences I...+0.01+0.90%
BNTCBenitec Biopharma Lt...+0.20+8.10%
PZRXPhaseRx Inc+0.07+4.82%
TENXTenax Therapeutics I...-0.01-0.87%
Data as of 3:26pm ET, 02/27/2017

Financials

Next reporting dateMay 23, 2017
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$15.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Fredric D. Price
Chief Medical Officer &
VP-Research
Warren W. Wasiewski
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts


Search for Jobs